InvestSMART

Bod Science Limited (ASX: BOD) - Announcements

DELISTED - Current share price for BOD : $0.024

ASX company news and announcements for Bod Science Limited (BOD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bod Science Limited (BOD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bod Science Limited (BOD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bod Science Limited (BOD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Gynecel Clinical Trial 28 Apr 2010 3:29PM $0.042 $0.024 fallen by 42.86%
- Successful 12 month evaluations cardiocel human trial 8 Apr 2010 3:03PM $0.058 $0.024 fallen by 58.62%
- Results from 12 Month Animal Hernia Trial 25 Mar 2010 3:56PM n/a $0.024 n/a
- Update on NAMSA biocompatibility testing 12 Mar 2010 11:15AM n/a $0.024 n/a
- Interim results from Cardiocel clinical trial 4 Mar 2010 11:37AM n/a $0.024 n/a
- Non renounceable rights issue of options 25 Feb 2010 6:45PM n/a $0.024 n/a
- Trading Halt 25 Feb 2010 10:04AM n/a $0.024 n/a
- Half Year Accounts 12 Feb 2010 2:15PM n/a $0.024 n/a
- Appendix 4C - quarterly 21 Jan 2010 12:12PM $0.049 $0.024 fallen by 51.02%
- NAMSA biocompatibility testing 15 Dec 2009 1:37PM n/a $0.024 n/a
- Australian Clinical Trial 9 Nov 2009 2:53PM n/a $0.024 n/a
- Appendix 4C - quarterly 15 Oct 2009 11:23AM n/a $0.024 n/a
- Preliminary Final Report 27 Aug 2009 6:40PM $0.058 $0.024 fallen by 58.62%
- Sydney Trial Ethics Approval 26 Aug 2009 1:57PM n/a $0.024 n/a
- Appendix 4C - quarterly 23 Jul 2009 10:35AM n/a $0.024 n/a
- Human trial first ten patients achieve significant milestone 16 Jul 2009 2:46PM $0.080 $0.024 fallen by 70%
- New patent for surgical tissue replacement eng technology 8 Jul 2009 12:16PM $0.035 $0.024 fallen by 31.43%
- Independent US Validation of ADAPT Tissue Technology 10 Jun 2009 11:46AM $0.030 $0.024 fallen by 20%
- Non rencounceable rights issue shortfall fully subscribed 1 May 2009 11:21AM $0.030 $0.024 fallen by 20%
- Appendix 4C - quarterly 30 Apr 2009 10:05AM n/a $0.024 n/a
- Non renounceable rights issue App 3B Prospectus 16 Feb 2009 3:38PM n/a $0.024 n/a
- Half Yearly Report and Accounts 6 Feb 2009 3:20PM $0.042 $0.024 fallen by 42.86%
- Appendix 4C - quarterly 8 Jan 2009 10:23AM n/a $0.024 n/a
- Appendix 4C - quarterly 22 Oct 2008 2:20PM n/a $0.024 n/a
- Phase II clinical trial update 9 Oct 2008 12:36PM $0.042 $0.024 fallen by 42.86%

226 - 250 of 298 results

Page 10 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.